Purchases and Sales Made in Q3 2022 in Seelos Therapeutics, Inc. (SEEL)
This table provides information about the institutional ownership of Seelos Therapeutics, Inc. (SEEL) during Q3 2022. The information is specifically focused on institutions that hold shares of SEELOS THERAPEUTICS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-416K- 85.0% |
$271K - $116M
|
73.5K
$27.9K
|
|
|
Nov 14, 2022
Q3 2022
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-460K- 39.66% |
$299K - $128M
|
699K
$266K
|
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-465K- 67.63% |
$302K - $130M
|
223K
$84.6K
|
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-668K- 42.09% |
$434K - $186M
|
919K
$349K
|
|
|
Nov 10, 2022
Q3 2022
|
Mirae Asset Global Investments Co., Ltd.
|
SELL
|
- |
-818K- 31.71% |
$531K - $228M
|
1.76M
$669K
|
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-954K- 82.66% |
$620K - $266M
|
200K
$76.1K
|